Marshall Wace
CNTB

Marshall Wace’s Connect Biopharma Holdings CNTB Stock Holding History

Marshall Wace’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$799K Buy
335,642
+269,629
+408% +$654K ﹤0.01% 2311
2026
Q1 		$173K Sell
66,013
-62,355
-49% -$163K ﹤0.01% 2813
2025
Q4 		$362K Buy
128,368
+70,337
+121% +$150K ﹤0.01% 2381
2025
Q3 		$85.9K Buy
+58,031
New +$103K ﹤0.01% 2674
2022
Q1 		– Sell
-123,109
Closed -$634K – 3428
2021
Q4 		$634K Buy
+123,109
New +$1.37M ﹤0.01% 2681

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Marshall Wace's CNTB Position: Q2 2026 in Review

Marshall Wace increased its Connect Biopharma Holdings (CNTB) stake by 408% in Q2 2026, buying an estimated $654K and bringing the position to 335,642 shares worth $799K. The position accounts for ﹤0.01% of the portfolio, ranked #2311.

Marshall Wace first reported a position in CNTB in Q4 2021 and has held it in 5 quarters since. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Marshall Wace held 335,642 shares of Connect Biopharma Holdings worth $799K as of Q2 2026.
  • Marshall Wace bought 269,629 Connect Biopharma Holdings shares in Q2 2026, an estimated $654K.
  • Connect Biopharma Holdings made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2311 holding.
  • Marshall Wace first reported a position in Connect Biopharma Holdings in Q4 2021 and has held it in 5 quarters since.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.